BCG Live (Organon Teknika)

N/A

Report date: 2026/05/18 20:02:07

Base Information

Drug NameBCG Live (Organon Teknika)
Drug Alias Name卡介苗TICEBCG VACCINETICE BCGTHERACYC +[6] 
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Urinary Bladder NeoplasmsColorectal Neoplasms +[12] 
Global Approved IndicationsUrinary Bladder NeoplasmsTuberculosis, Pulmonary
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/08/21
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOrganon
China Registration ClassN/A

Develop Information

Active CompaniesImmunitybio IncNational Cancer InstituteUniversity Of Virginia
Inactive CompaniesRadboud University Medical CenterRoswell Park Cancer InstituteEarle A. Chiles Research Institute +[7] 
Active IndicationsUrinary Bladder NeoplasmsCarcinoma, Transitional CellTuberculosis, Pulmonary +[5] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Colorectal NeoplasmsBreast Neoplasms +[7] 

Other Information

ATC CodeL03AX03
Related LinksN/A